E-LIB Suche - Ergebnisse für: Bartlett, Nancy L

1

Mosunetuzumab Safety Profile in Patients With Relapsed/Refr..:

Matasar, Matthew ; Bartlett, Nancy L. ; Shadman, Mazyar...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 4 - p. 240-253 , 2024

Link: https://doi.org/10.1016/..

2

Blinatumomab consolidation post–autologous stem cell transp..:

Ghobadi, Armin ; Foley, Nicole C. ; Cohen, Jared...
Blood Advances. 8 (2024) 3 - p. 513-522 , 2024

Link: https://doi.org/10.1182/..

3

Outcomes of marginal zone lymphoma treated with ibrutinib i..:

Epperla, Narendranath ; Zhao, Qiuhong ; Moyo, Tamara...
Blood Advances. 8 (2024) 3 - p. 549-552 , 2024

Link: https://doi.org/10.1182/..

4

Phase I Study of Duvelisib Study for Cytokine Release Syndr..:

Slade, Michael ; Rettig, Michael P. ; Crees, Zachary D...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S118-S119 , 2024

Link: https://doi.org/10.1016/..

5

Impact of imaging frequency on progression-free survival in..:

Rutherford, Sarah C. ; Yin, Jun ; Pederson, Levi D....
Blood Advances. 8 (2024) 6 - p. 1464-1468 , 2024

Link: https://doi.org/10.1182/..

6

Long-term outcomes of patients with large B-cell lymphoma t..:

Oluwole, Olalekan O. ; Forcade, Edouard ; Muñoz, Javier...
Bone Marrow Transplantation. 59 (2024) 3 - p. 366-372 , 2024

Link: https://doi.org/10.1038/..

7

Myeloablative vs nonmyeloablative consolidation for primary..:

Batchelor, Tracy T. ; Giri, Sharmila ; Ruppert, Amy S....
Blood Advances. 8 (2024) 12 - p. 3189-3199 , 2024

Link: https://doi.org/10.1182/..

8

Loss of CD20 expression as a mechanism of resistance to mos..:

Schuster, Stephen J. ; Huw, Ling-Yuh ; Bolen, Christopher R....
Blood. 143 (2024) 9 - p. 822-832 , 2024

Link: https://doi.org/10.1182/..

9

Neoantigen Landscape Supports Feasibility of Personalized C..:

Ramirez, Cody A ; Becker-Hapak, Michelle ; Singhal, Kartik...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

10

P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATI..:

Sehn, Laurie H. ; Bartlett, Nancy L. ; Matasar, Matthew...
HemaSphere. 7 (2023) S3 - p. e36694eb , 2023

Link: https://doi.org/10.1097/..

11

A phase 1 first‐in‐human study of GS‐0189, an anti‐signal r..:

Narkhede, Mayur ; Bartlett, Nancy L. ; Ibrahimi, Sami...
eJHaem. 4 (2023) 2 - p. 370-380 , 2023

Link: https://doi.org/10.1002/..

12

IBCL-489 Mosunetuzumab Retreatment Is Effective and Well-To..:

Cheah, Chan Yoon ; Bartlett, Nancy L. ; Assouline, Sarit...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S455 , 2023

Link: https://doi.org/10.1016/..

13

A multi-cohort phase 1b trial of rituximab in combination w..:

Merryman, Reid W. ; Redd, Robert A. ; Freedman, Arnold S....
Annals of Hematology. , 2023

Link: https://doi.org/10.1007/..

14

Genetic subgroups inform on pathobiology in adult and pedia..:

Thomas, Nicole ; Dreval, Kostiantyn ; Gerhard, Daniela S....
Blood. 141 (2023) 8 - p. 904-916 , 2023

Link: https://doi.org/10.1182/..

15

POSTER: TCL-054 A Multi-Institutional Prospective Cohort St..:

Foley, Nicole ; Russler-Germain, David ; Watkins, Marcus...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S213 , 2023

Link: https://doi.org/10.1016/..